BioSpace News Archive

Enzo Biochem, Inc., a leading biotechnology and diagnostic company, announced its wholly owned subsidiary, Enzo Clinical Labs, Inc., has expanded its screening services for COVID-19.

Scholar Rock announced an oral presentation on SRK-015, a highly specific inhibitor of the activation of latent myostatin, at the Muscular Dystrophy Association Clinical & Scientific Conference.

GE Healthcare and Ford collaborate to accelerate and scale ventilator production, supporting clinicians in the treatment of COVID-19 patients

3M and Ford will collaborate on making more powered air purifying respirators to help in the fight against the COVID-19 outbreak

Windtree Therapeutics, Inc., a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, announced it is planning to study its proprietary KL4 surfactant to potentially mitigate the pulmonary effects of severe COVID-19 infection.

Avails Medical, a pioneer in automated, accelerated antibiotic susceptibility testing (AST) for septic patients announced today the participation of OMRON VENTURES Co., Ltd. in its current equity financing round.

Paul Bisaro and Gail Naughton, Ph.D., Appointed as Independent Directors –

DiaCarta Inc., a precision molecular diagnostic company, announced today that it has filed for Emergency Use Authorization (EUA) with the US FDA for its QuantiVirus™ SARS-CoV-2 test and has validated the COVID-19 diagnostic test in its own CLIA certified lab in Richmond, CA to provide testing services for healthcare providers an

Derm-Biome Pharmaceuticals, Inc, a private Vancouver based start-up biopharmaceutical company focused on skin health and healthy ageing, is pleased to announce that one of its topical drugs produced significant, and dose dependent inhibitory effects in a well established mouse model of atopic dermatitis (AD)

ReWalk Robotics Ltd. a global leader in Exoskeleton technology for community use and rehabilitation centers, issued the following letter to shareholders